TipRanks
TipRanksTop Financial ExpertsInsidersFranklin Berger

Franklin Berger Insider Profile

18 Followers
Franklin Berger, Director at Retension Pharmaceuticals Inc, holds 22.52K shares in Retension Pharmaceuticals Inc (Ticker: RTSN), holds 0.00 shares in Five Prime Therapeutics (Ticker: FPRX), holds 306.16K shares in Kineta (Ticker: KANT).
See the Hottest Stocks Based on Insider Trading >
tipranks
Franklin Berger

Franklin Berger
Retension Pharmaceuticals Inc (RTSN)
Director

Ranked #103,497 out of 109,349 Corporate Insiders

Profitable Transactions

35%
13 out of 37 Profitable Transactions

Average Return

-20.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$2M
89.58%
10.40%
0.02%
A breakdown of Franklin Berger's holdings
See the Top Stocks by Insiders

Insider Roles

Atea Pharmaceuticals
(AVIR)
Director
Retension Pharmaceuticals Inc
(RTSN)
Director
Lineage Therap
(LCTX)
Director
Roles that Franklin Berger holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Five Prime Therapeutics
(FPRX)
Rating:Informative Buy
Date:Sep 24, 2015 - Sep 24, 2016
Return:+181.70%
The most profitable trade made by Franklin Berger
See the Latest Stocks Traded by Insiders

Franklin Berger's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
RTSN
Retension Pharmaceuticals Inc
Oct 13, 2026
Director
Uninformative Buy
―
$255.79K
FPRX
Five Prime Therapeutics
Apr 19, 2021
―
Uninformative Sell
190.00K
$0.00
KANT
Kineta
Oct 26, 2018
―
Informative Buy
270.00K
$102.87K
FBRX
Forte Biosciences
―
―
―
―
KZR
Kezar Life Sciences
May 11, 2026
―
Uninformative Sell
―
$0.00
BCEL
Atreca
Jun 24, 2019
―
Uninformative Buy
―
$8.80K
AVIR
Atea Pharmaceuticals
Jun 23, 2026
Director
Uninformative Buy
129.06K
$2.20M
EPIX
ESSA Pharma
Nov 22, 2023
―
Informative Buy
133.27K
$157.67K
~RAIN
Rain Oncology
Jan 26, 2024
―
Uninformative Sell
―
$0.00
IMDZ
Immune Design
Apr 04, 2019
―
Uninformative Sell
438.75K
$0.00
SGEN
Seagen
Feb 25, 2014
―
Informative Buy
95.70K
$46.83M
LCTX
Lineage Therap
Aug 22, 2013
Director
Informative Buy
1.85K
$500.00
~EMIS
Emisphere Technologies
―
―
―
$0.00
AST
Asterias Biotherapeutics
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Franklin Berger's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Franklin Berger insider profile FAQ

What is the percentage of profitable transactions made by Franklin Berger?
The percentage of profitable transactions made by Franklin Berger is 35%.
    What is the average return per transaction made by Franklin Berger?
    The average return per transaction made by Franklin Berger is -20.50%.
      What stocks does Franklin Berger hold?
      Franklin Berger holds: RTSN, FPRX, KANT, FBRX, KZR, BCEL, AVIR, EPIX, ~RAIN, IMDZ, SGEN, LCTX, ~EMIS, AST stocks.
        What was Franklin Berger’s latest transaction?
        Franklin Berger latest transaction was an Uninformative Buy of ―.
          What was Franklin Berger's most profitable transaction?
          Franklin Berger’s most profitable transaction was an Informative Buy of FPRX stock on September 24, 2015. The return on the trade was 181.70%.
            What is Franklin Berger's role in Retension Pharmaceuticals Inc?
            Franklin Berger's role in Retension Pharmaceuticals Inc is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.